Cannabinoids – the possible use in palliative medicine

Tomasz Dzierżanowski

doi:10.5114/pm.2018.77198

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

1/2018
vol. 10

Send email

Copy url:

abstract:

Review paper

Cannabinoids – the possible use in palliative medicine

Tomasz Dzierżanowski

Medycyna Paliatywna 2018; 10(1): 1–11

DOI: https://doi.org/10.5114/pm.2018.77198

Online publish date: 2018/06/30

View full text Get citation

PlumX metrics:

The interest in the use of cannabinoids in palliative care has increased in recent years. Their multi-directional action, although of limited effectiveness, makes them an attractive alternative, especially in patients with multiple concomitant symptoms. There is evidence of the effectiveness of cannabinoids in indications such as pain, spasticity, seizures, sleep disorder, nausea and vomiting, and Tourette syndrome. Although the effectiveness of pain management is limited, it is evident in neuropathic pain and the adjuvant treatment along with opioids. Due to their favorable adverse effects profile and lack of depressive impact on the respiratory system, cannabinoids can supplement the relatively narrow set of medicines at the disposal of the palliative medicine physician.

keywords:

Cannabinoids – the possible use in palliative medicine

Tomasz Dzierżanowski

cannabinoids, palliative care